https://news.medxy.ai/extended-release-vs-sublingual-buprenorphine-in-pregnancy-through-12-months-post-partum-a-randomized-clinical-trial/Medxy AIen2026-05-11T20:09:29-07:00Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial https://news.medxy.ai/vi/khoi-dau-duoc-pham-cho-roi-loan-su-dung-ruou-trong-cuu-chien-binh-nhap-vien-mot-nghien-cuu-doi-ngu-quay-lai/Medxy AIvi2026-05-11T20:02:23-07:00Khởi đầu Dược phẩm cho Rối loạn Sử dụng Rượu trong Cựu chiến binh Nhập viện: Một Nghiên cứu Đội Ngũ Quay Lại https://news.medxy.ai/ja/%e3%82%a2%e3%83%ab%e3%82%b3%e3%83%bc%e3%83%ab%e4%bd%bf%e7%94%a8%e9%9a%9c%e5%ae%b3%e3%81%ae%e6%b2%bb%e7%99%82%e8%96%ac%e6%8a%95%e4%b8%8e%e9%96%8b%e5%a7%8b%e3%81%ab%e3%81%a4%e3%81%84%e3%81%a6%e3%81%ae/Medxy AIja2026-05-11T20:01:20-07:00アルコール使用障害の治療薬投与開始についての入院退役軍人: 回顧的コホート研究 https://news.medxy.ai/zh/%e4%bd%8f%e9%99%a2%e9%80%80%e4%bc%8d%e5%86%9b%e4%ba%ba%e9%85%92%e7%b2%be%e4%bd%bf%e7%94%a8%e9%9a%9c%e7%a2%8d%e8%8d%af%e7%89%a9%e6%b2%bb%e7%96%97%e7%9a%84%e5%90%af%e5%8a%a8%ef%bc%9a%e4%b8%80%e9%a1%b9/Medxy AIzh2026-05-11T20:00:15-07:00住院退伍军人酒精使用障碍药物治疗的启动：一项回顾性队列研究 https://news.medxy.ai/initiation-of-medications-for-alcohol-use-disorder-among-hospitalized-veterans-a-retrospective-cohort-study/Medxy AIen2026-05-11T19:56:47-07:00Initiation of Medications for Alcohol Use Disorder Among Hospitalized Veterans : A Retrospective Cohort Study https://news.medxy.ai/molecular-profiling-refines-relapse-risk-after-allogeneic-transplant-in-first-remission-acute-myeloid-leukemia/Medxy AIen2026-05-11T19:52:49-07:00Molecular Profiling Refines Relapse Risk After Allogeneic Transplant in First-Remission Acute Myeloid Leukemia https://news.medxy.ai/a-new-ctcl-specific-quality-of-life-tool-shows-strong-early-validity-signals-in-cutaneous-t-cell-lymphoma/Medxy AIen2026-05-11T17:21:00-07:00A New CTCL-Specific Quality-of-Life Tool Shows Strong Early Validity Signals in Cutaneous T-Cell Lymphoma https://news.medxy.ai/vi/lieu-phap-te-bao-t-car-nham-muc-tieu-cd117-cho-thay-hua-hen-chong-lai-mastocytosis-he-thong-tien-trien-trong-cac-nghien-cuu-tien-lam-sang/Medxy AIvi2026-05-11T17:04:27-07:00Liệu pháp tế bào T CAR nhắm mục tiêu CD117 cho thấy hứa hẹn chống lại Mastocytosis hệ thống tiến triển trong các nghiên cứu tiền lâm sàng https://news.medxy.ai/ja/cd117%e3%82%92%e6%a8%99%e7%9a%84%e3%81%a8%e3%81%99%e3%82%8bcar-t%e7%b4%b0%e8%83%9e%e7%99%82%e6%b3%95%e3%80%81%e5%89%8d%e8%87%a8%e5%ba%8a%e7%a0%94%e7%a9%b6%e3%81%a7%e9%80%b2%e8%a1%8c%e6%80%a7%e5%85%a8/Medxy AIja2026-05-11T17:03:05-07:00CD117を標的とするCAR T細胞療法、前臨床研究で進行性全身性マスト細胞症に対する有望な効果を示す https://news.medxy.ai/zh/%e9%9d%b6%e5%90%91cd117%e7%9a%84car-t%e7%bb%86%e8%83%9e%e7%96%97%e6%b3%95%e5%9c%a8%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6%e4%b8%ad%e5%af%b9%e6%99%9a%e6%9c%9f%e7%b3%bb%e7%bb%9f%e6%80%a7%e8%82%a5/Medxy AIzh2026-05-11T17:02:10-07:00靶向CD117的CAR T细胞疗法在临床前研究中对晚期系统性肥大细胞增多症显示前景 https://news.medxy.ai/vi/nghien-cuu-cho-thay-thoi-gian-truyen-khong-anh-huong-den-ket-qua-dieu-tri-bang-lieu-phap-te-bao-t-car-cho-lymphoma-te-bao-b-lon/Medxy AIvi2026-05-11T17:01:54-07:00Nghiên cứu cho thấy thời gian truyền không ảnh hưởng đến kết quả điều trị bằng liệu pháp tế bào T CAR cho lymphoma tế bào B lớn https://news.medxy.ai/zh/%e7%a0%94%e7%a9%b6%e5%8f%91%e7%8e%b0%e8%be%93%e6%b3%a8%e6%97%b6%e9%97%b4%e4%b8%8d%e5%bd%b1%e5%93%8d%e5%a4%a7b%e7%bb%86%e8%83%9e%e6%b7%8b%e5%b7%b4%e7%98%a4%e7%9a%84car-t%e7%bb%86%e8%83%9e%e6%b2%bb-2/Medxy AIzh2026-05-11T17:01:10-07:00研究发现输注时间不影响大B细胞淋巴瘤的CAR T细胞治疗效果 https://news.medxy.ai/ja/%e7%a0%94%e7%a9%b6%e5%8f%91%e7%8e%b0%e8%be%93%e6%b3%a8%e6%97%b6%e9%97%b4%e4%b8%8d%e5%bd%b1%e5%93%8d%e5%a4%a7b%e7%bb%86%e8%83%9e%e6%b7%8b%e5%b7%b4%e7%98%a4%e7%9a%84car-t%e7%bb%86%e8%83%9e%e6%b2%bb/Medxy AIja2026-05-11T17:00:37-07:00研究发现输注时间不影响大B细胞淋巴瘤的CAR T细胞治疗结果 https://news.medxy.ai/car-t-cell-therapy-targeting-cd117-shows-promise-against-advanced-systemic-mastocytosis-in-preclinical-studies/Medxy AIen2026-05-11T17:00:26-07:00CAR T-Cell Therapy Targeting CD117 Shows Promise Against Advanced Systemic Mastocytosis in Preclinical Studies https://news.medxy.ai/study-finds-infusion-timing-does-not-affect-car-t-cell-therapy-outcomes-for-large-b-cell-lymphoma/Medxy AIen2026-05-11T16:58:53-07:00Study Finds Infusion Timing Does Not Affect CAR T-Cell Therapy Outcomes for Large B-Cell Lymphoma https://news.medxy.ai/vi/quan-diem-cua-ban-khoa-hoc-gold-ve-con-bung-phat-va-nguy-co-tim-mach-trong-copd/Medxy AIvi2026-05-11T16:58:16-07:00Quan điểm của Ban Khoa học GOLD về cơn bùng phát và nguy cơ tim mạch trong COPD https://news.medxy.ai/zh/gold%e7%a7%91%e5%ad%a6%e5%a7%94%e5%91%98%e4%bc%9a%e5%85%b3%e4%ba%8ecopd%e5%8a%a0%e9%87%8d%e4%b8%8e%e5%bf%83%e8%a1%80%e7%ae%a1%e9%a3%8e%e9%99%a9%e7%9a%84%e8%a7%82%e7%82%b9/Medxy AIzh2026-05-11T16:57:24-07:00GOLD科学委员会关于COPD加重与心血管风险的观点 https://news.medxy.ai/ja/copd%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e6%80%a5%e6%80%a7%e5%a2%97%e6%82%aa%e3%81%a8%e5%bf%83%e8%a1%80%e7%ae%a1%e3%83%aa%e3%82%b9%e3%82%af%e3%81%ab%e9%96%a2%e3%81%99%e3%82%8bgold%e7%a7%91%e5%ad%a6/Medxy AIja2026-05-11T16:56:48-07:00COPDにおける急性増悪と心血管リスクに関するGOLD科学委員会の見解 https://news.medxy.ai/a-gold-science-committee-perspective-on-exacerbations-and-cardiovascular-risk-in-copd/Medxy AIen2026-05-11T16:53:33-07:00A GOLD Science Committee Perspective on Exacerbations and Cardiovascular Risk In COPD https://news.medxy.ai/vi/su-tuong-quan-giua-kieu-gen-va-kieu-hinh-trong-loan-duong-vong-mac-lien-quan-den-rpgrip1-o-mot-nhom-benh-nhan-nhat-ban-tren-toan-quoc/Medxy AIvi2026-05-11T16:53:17-07:00Sự tương quan giữa kiểu gen và kiểu hình trong loạn dưỡng võng mạc liên quan đến RPGRIP1 ở một nhóm bệnh nhân Nhật Bản trên toàn quốc https://news.medxy.ai/zh/%e6%97%a5%e6%9c%ac%e5%85%a8%e5%9b%bd%e9%98%9f%e5%88%97%e4%b8%adrpgrip1%e7%9b%b8%e5%85%b3%e8%a7%86%e7%bd%91%e8%86%9c%e8%90%a5%e5%85%bb%e4%b8%8d%e8%89%af%e7%9a%84%e5%9f%ba%e5%9b%a0%e5%9e%8b-%e8%a1%a8/Medxy AIzh2026-05-11T16:52:21-07:00日本全国队列中RPGRIP1相关视网膜营养不良的基因型-表型相关性 https://news.medxy.ai/ja/%e6%97%a5%e6%9c%ac%e5%85%a8%e5%9b%bd%e3%82%b3%e3%83%9b%e3%83%bc%e3%83%88%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8brpgrip1%e9%96%a2%e9%80%a3%e7%b6%b2%e8%86%9c%e5%a4%89%e6%80%a7%e3%81%ae%e3%82%b2%e3%83%8e/Medxy AIja2026-05-11T16:51:30-07:00日本全国コホートにおけるRPGRIP1関連網膜変性のゲノタイプ-フェノタイプ相関 https://news.medxy.ai/genotype-phenotype-correlations-in-rpgrip1-associated-retinal-dystrophy-in-a-nationwide-japanese-cohort/Medxy AIen2026-05-11T16:49:18-07:00Genotype-phenotype correlations in RPGRIP1-associated retinal dystrophy in a nationwide Japanese cohort https://news.medxy.ai/vi/cong-cu-ho-tro-quyet-dinh-ve-amblyopia-dua-tren-web/Medxy AIvi2026-05-11T15:33:11-07:00Công cụ hỗ trợ quyết định về Amblyopia dựa trên web https://news.medxy.ai/ja/%e3%82%a6%e3%82%a7%e3%83%96%e3%83%99%e3%83%bc%e3%82%b9%e3%81%ae%e5%bc%b1%e8%a6%96%e8%a8%ba%e6%96%ad%e6%94%af%e6%8f%b4%e3%83%84%e3%83%bc%e3%83%ab/Medxy AIja2026-05-11T15:32:16-07:00ウェブベースの弱視診断支援ツール https://news.medxy.ai/zh/%e5%9f%ba%e4%ba%8e%e7%bd%91%e7%bb%9c%e7%9a%84%e5%bc%b1%e8%a7%86%e5%86%b3%e7%ad%96%e6%94%af%e6%8c%81%e5%b7%a5%e5%85%b7/Medxy AIzh2026-05-11T15:31:28-07:00基于网络的弱视决策支持工具 https://news.medxy.ai/web-based-amblyopia-decision-support-tool/Medxy AIen2026-05-11T15:29:17-07:00Web-Based Amblyopia Decision Support Tool https://news.medxy.ai/zh/0-05-%e4%b8%99%e9%85%b8%e6%b0%af%e5%80%8d%e4%bb%96%e7%b4%a2%e6%b7%b7%e6%82%ac%e6%bb%b4%e7%9c%bc%e6%b6%b2%ef%bc%9a%e7%99%bd%e5%86%85%e9%9a%9c%e6%9c%af%e5%90%8e%e7%82%8e%e7%97%87%e5%92%8c%e7%96%bc/Medxy AIzh2026-05-11T14:58:41-07:000.05% 丙酸氯倍他索混悬滴眼液：白内障术后炎症和疼痛管理的新里程碑 https://news.medxy.ai/ja/%e3%82%af%e3%83%ad%e3%83%99%e3%82%bf%e3%82%bd%e3%83%bc%e3%83%ab%e3%83%97%e3%83%ad%e3%83%94%e3%82%aa%e3%83%8d%e3%83%bc%e3%83%88%e7%9c%bc%e7%94%a8%e6%87%b8%e6%bf%81%e6%b6%b2-0-05%ef%bc%9a%e7%99%bd/Medxy AIja2026-05-11T14:56:38-07:00クロベタソールプロピオネート眼用懸濁液 0.05%：白内障手術後の炎症と疼痛管理における新しい治療のマイルストーン https://news.medxy.ai/vi/suspensi-ocular-clobetasol-propionate-005-mot-dot-pha-trong-quan-ly-viem-va-dau-sau-phau-thuat-thuy-tinh-the/Medxy AIvi2026-05-11T14:54:00-07:00Suspensi Ocular Clobetasol Propionate 0,05%: Một Đột Phá Trong Quản Lý Viêm và Đau Sau Phẫu Thuật Thủy Tinh Thể https://news.medxy.ai/clobetasol-propionate-ophthalmic-suspension-0-05-a-new-therapeutic-milestone-in-post-cataract-surgery-inflammation-and-pain-management/Medxy AIen2026-05-11T14:49:55-07:00Clobetasol Propionate Ophthalmic Suspension 0.05%: A New Therapeutic Milestone in Post-Cataract Surgery Inflammation and Pain Management https://news.medxy.ai/a-cbt-based-mobile-app-significantly-reduced-tinnitus-distress-in-a-sham-controlled-randomized-trial/Medxy AIen2026-05-11T14:34:53-07:00A CBT-Based Mobile App Significantly Reduced Tinnitus Distress in a Sham-Controlled Randomized Trial https://news.medxy.ai/3d-printed-temporal-bones-provide-a-reliable-objective-way-to-assess-mastoidectomy-skill-across-otolaryngology-training/Medxy AIen2026-05-11T12:20:28-07:003D-Printed Temporal Bones Provide a Reliable, Objective Way to Assess Mastoidectomy Skill Across Otolaryngology Training https://news.medxy.ai/adrenalectomy-for-mild-autonomous-cortisol-secretion-was-linked-to-lower-mortality-but-the-survival-signal-requires-cautious-interpretation/Medxy AIen2026-05-11T11:57:25-07:00Adrenalectomy for Mild Autonomous Cortisol Secretion Was Linked to Lower Mortality, but the Survival Signal Requires Cautious Interpretation https://news.medxy.ai/vi/phan-tan-da-day-tuyen-tuy-de-dieu-tri-beo-phi-nang-nghien-cuu-dot-pha-50-nam-tiet-lo-loi-ich-va-nguy-co-tron-doi/Medxy AIvi2026-05-11T11:18:55-07:00Phân Tán Dạ Dày – Tuyến Tuỵ để Điều Trị Béo Phì Nặng: Nghiên Cứu Đột Phá 50 Năm Tiết Lộ Lợi Ích và Nguy Cơ Trọn Đời https://news.medxy.ai/ja/%e9%87%8d%e5%ba%a6%e8%82%a5%e6%ba%80%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e8%83%86%e8%86%b5%e3%83%90%e3%82%a4%e3%83%91%e3%82%b9%ef%bc%9a50%e5%b9%b4%e9%96%93%e3%81%ae%e7%a0%94%e7%a9%b6%e3%81%a7%e7%94%9f/Medxy AIja2026-05-11T11:17:19-07:00重度肥満に対する胆膵バイパス：50年間の研究で生涯にわたる利益とリスクが明らかに https://news.medxy.ai/zh/%e8%83%86%e8%83%b0%e5%88%86%e6%b5%81%e6%9c%af%e6%b2%bb%e7%96%97%e9%87%8d%e5%ba%a6%e8%82%a5%e8%83%96%ef%bc%9a50%e5%b9%b4%e7%a0%94%e7%a9%b6%e6%8f%ad%e7%a4%ba%e7%bb%88%e8%ba%ab%e7%9b%8a%e5%a4%84%e4%b8%8e/Medxy AIzh2026-05-11T11:16:03-07:00胆胰分流术治疗重度肥胖：50年研究揭示终身益处与风险 https://news.medxy.ai/biliopancreatic-diversion-for-severe-obesity-landmark-50-year-study-reveals-lifelong-benefits-and-risks/Medxy AIen2026-05-11T11:12:27-07:00Biliopancreatic Diversion for Severe Obesity: Landmark 50-Year Study Reveals Lifelong Benefits and Risks https://news.medxy.ai/vi/lieu-phap-estrogen-lien-quan-den-cai-thien-su-song-sot-o-mot-so-benh-nhan-ung-thu-buong-trung-duoi-60-tuoi/Medxy AIvi2026-05-11T11:09:44-07:00Liệu pháp estrogen liên quan đến cải thiện sự sống sót ở một số bệnh nhân ung thư buồng trứng dưới 60 tuổi https://news.medxy.ai/ja/60%e6%ad%b3%e6%9c%aa%e6%ba%80%e3%81%ae%e7%89%b9%e5%ae%9a%e5%8d%b5%e5%b7%a3%e3%81%8c%e3%82%93%e6%82%a3%e8%80%85%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e3%82%a8%e3%82%b9%e3%83%88%e3%83%ad%e3%82%b2%e3%83%b3/Medxy AIja2026-05-11T11:08:42-07:0060歳未満の特定卵巣がん患者におけるエストロゲン療法と生存率向上の関連 https://news.medxy.ai/zh/%e9%9b%8c%e6%bf%80%e7%b4%a0%e6%b2%bb%e7%96%97%e4%b8%8e60%e5%b2%81%e4%bb%a5%e4%b8%8b%e6%9f%90%e4%ba%9b%e5%8d%b5%e5%b7%a2%e7%99%8c%e6%82%a3%e8%80%85%e7%9a%84%e7%94%9f%e5%ad%98%e6%94%b9%e5%96%84%e7%9b%b8/Medxy AIzh2026-05-11T11:07:56-07:00雌激素治疗与60岁以下某些卵巢癌患者的生存改善相关 https://news.medxy.ai/estrogen-therapy-linked-to-improved-survival-in-certain-ovarian-cancer-patients-under-60/Medxy AIen2026-05-11T11:05:50-07:00Estrogen Therapy Linked to Improved Survival in Certain Ovarian Cancer Patients Under 60 https://news.medxy.ai/zh/%e5%a6%8a%e5%a8%a0%e6%97%a9%e6%9c%9f%e6%af%8d%e4%bd%93cmv%e6%84%9f%e6%9f%93%e9%9b%86%e4%b8%ad%e5%a2%9e%e5%8a%a0%e8%83%8e%e5%84%bf%e8%84%91%e6%8d%9f%e4%bc%a4%e3%80%81%e5%90%ac%e5%8a%9b%e6%8d%9f/Medxy AIzh2026-05-11T10:58:04-07:00妊娠早期母体CMV感染集中增加胎儿脑损伤、听力损失和自闭症谱系障碍的风险 https://news.medxy.ai/ja/%e5%a6%8a%e5%a8%a0%e5%88%9d%e6%9c%9f%e3%81%ae%e6%af%8d%e4%bd%93cmv%e6%84%9f%e6%9f%93%e3%81%af%e8%83%8e%e5%85%90%e8%84%b3%e6%90%8d%e5%82%b7%e3%80%81%e8%81%b4%e8%a6%9a%e9%9a%9c%e5%ae%b3%e3%80%81/Medxy AIja2026-05-11T10:56:09-07:00妊娠初期の母体CMV感染は胎児脳損傷、聴覚障害、自閉症スペクトラム障害のリスクを集中させる https://news.medxy.ai/low-dose-aspirins-pregnancy-benefit-appears-unchanged-by-start-time-or-adherence-in-a-large-multicentre-post-hoc-trial-analysis/Medxy AIen2026-05-11T10:55:37-07:00Low-Dose Aspirin’s Pregnancy Benefit Appears Unchanged by Start Time or Adherence in a Large Multicentre Post Hoc Trial Analysis https://news.medxy.ai/vi/nhiem-cmv-thai-ky-dau-tap-trung-nguy-co-ton-thuong-nao-thai-nhi-mat-thinh-luc-va-roi-loan-pho-tu-ky/Medxy AIvi2026-05-11T10:52:36-07:00Nhiễm CMV thai kỳ đầu tập trung nguy cơ tổn thương não thai nhi, mất thính lực và rối loạn phổ tự kỷ https://news.medxy.ai/first-trimester-maternal-cmv-infection-concentrates-the-risk-of-fetal-brain-injury-hearing-loss-and-autism-spectrum-disorder/Medxy AIen2026-05-11T10:48:07-07:00First-Trimester Maternal CMV Infection Concentrates the Risk of Fetal Brain Injury, Hearing Loss, and Autism Spectrum Disorder https://news.medxy.ai/a-body-surface-area-adjusted-bevacizumab-target-was-linked-to-better-survival-in-atezolizumab-treated-unresectable-hepatocellular-carcinoma/Medxy AIen2026-05-10T23:26:05-07:00A Body Surface Area–Adjusted Bevacizumab Target Was Linked to Better Survival in Atezolizumab-Treated Unresectable Hepatocellular Carcinoma https://news.medxy.ai/a-stromal-cthrc1-biomarker-framework-may-identify-colorectal-cancers-with-poor-prognosis-and-limited-immunotherapy-benefit/Medxy AIen2026-05-10T23:23:39-07:00A Stromal CTHRC1 Biomarker Framework May Identify Colorectal Cancers With Poor Prognosis and Limited Immunotherapy Benefit https://news.medxy.ai/weak-grip-slow-walking-pace-and-sarcopenia-signal-higher-risk-of-incident-stroke-and-worse-poststroke-survival-in-uk-biobank/Medxy AIen2026-05-10T23:21:44-07:00Weak Grip, Slow Walking Pace, and Sarcopenia Signal Higher Risk of Incident Stroke and Worse Poststroke Survival in UK Biobank https://news.medxy.ai/multiple-sclerosis-end-of-life-care-remains-hospital-centered-despite-comparable-palliative-care-use/Medxy AIen2026-05-10T23:19:29-07:00Multiple Sclerosis End-of-Life Care Remains Hospital-Centered Despite Comparable Palliative Care Use https://news.medxy.ai/adjunct-intra-arterial-alteplase-after-successful-basilar-thrombectomy-was-safe-but-did-not-improve-90-day-outcomes-in-iat-top/Medxy AIen2026-05-10T23:16:35-07:00Adjunct Intra-arterial Alteplase After Successful Basilar Thrombectomy Was Safe but Did Not Improve 90-Day Outcomes in IAT-TOP https://news.medxy.ai/subclinical-hyperthyroidism-carries-measurable-risks-of-atrial-fibrillation-heart-failure-and-death-in-primary-care/Medxy AIen2026-05-10T23:13:50-07:00Subclinical Hyperthyroidism Carries Measurable Risks of Atrial Fibrillation, Heart Failure, and Death in Primary Care https://news.medxy.ai/advanced-liver-imaging-reveals-impaired-postprandial-hepatic-glucose-handling-and-hidden-metabolic-subtypes-in-type-1-diabetes/Medxy AIen2026-05-10T17:51:27-07:00Advanced Liver Imaging Reveals Impaired Postprandial Hepatic Glucose Handling and Hidden Metabolic Subtypes in Type 1 Diabetes https://news.medxy.ai/ja/%e3%82%af%e3%83%a9%e3%82%a4%e3%83%b3%e3%82%bb%e3%83%ab%e3%83%95%e3%82%a9%e3%83%b3%e3%83%88%e6%8a%95%e4%b8%8e%e9%96%8b%e5%a7%8b%e5%be%8c%e3%81%ae%e5%b0%8f%e5%85%90%e3%82%af%e3%83%a9%e3%82%b7%e3%83%83/Medxy AIja2026-05-10T17:43:14-07:00クラインセルフォント投与開始後の小児クラシックCAH患者におけるグルココルチコイド減量: 実践的見解 https://news.medxy.ai/vi/giam-glucocorticoid-sau-khi-bat-dau-su-dung-crinecerfont-o-benh-nhi-voi-cah-dien-hinh-quan-diem-thuc-tien/Medxy AIvi2026-05-10T17:41:38-07:00Giảm Glucocorticoid Sau Khi Bắt Đầu Sử Dụng Crinecerfont ở Bệnh Nhi Với CAH Điển Hình: Quan Điểm Thực Tiễn https://news.medxy.ai/zh/%e5%9c%a8%e7%bb%8f%e5%85%b8%e5%85%88%e5%a4%a9%e6%80%a7%e8%82%be%e4%b8%8a%e8%85%ba%e7%9a%ae%e8%b4%a8%e5%a2%9e%e7%94%9f%e7%97%87%e5%84%bf%e7%a7%91%e6%82%a3%e8%80%85%e4%b8%ad%e5%bc%80%e5%a7%8b%e4%bd%bf/Medxy AIzh2026-05-10T17:40:04-07:00在经典先天性肾上腺皮质增生症儿科患者中开始使用克林塞丰后的糖皮质激素减量：实用视角 https://news.medxy.ai/glucocorticoid-reduction-after-starting-crinecerfont-in-pediatric-patients-with-classic-cah-practical-perspectives/Medxy AIen2026-05-10T17:38:08-07:00Glucocorticoid Reduction After Starting Crinecerfont in Pediatric Patients With Classic CAH: Practical Perspectives https://news.medxy.ai/pediatric-type-1-diabetes-care-still-misses-ldl-targets-despite-clear-indications-for-lipid-lowering-therapy/Medxy AIen2026-05-10T17:30:35-07:00Pediatric Type 1 Diabetes Care Still Misses LDL Targets Despite Clear Indications for Lipid-Lowering Therapy https://news.medxy.ai/multi-ancestry-polygenic-risk-scores-substantially-improve-type-2-diabetes-risk-prediction-across-diverse-populations/Medxy AIen2026-05-10T16:49:06-07:00Multi-ancestry Polygenic Risk Scores Substantially Improve Type 2 Diabetes Risk Prediction Across Diverse Populations https://news.medxy.ai/vi/ly-do-va-thiet-ke-cua-cardio-ttransform-thu-nghiem-giai-doan-3-cua-eplontersen-cho-benh-co-tim-amyloid-transthyretin/Medxy AIvi2026-05-10T16:48:06-07:00Lý do và Thiết kế của CARDIO-TTRansform: Thử nghiệm Giai đoạn 3 của Eplontersen cho Bệnh cơ tim Amyloid Transthyretin https://news.medxy.ai/ja/cardio-ttransform%e3%81%ae%e7%90%86%e7%94%b1%e3%81%a8%e8%a8%ad%e8%a8%88-transthyretin-%e3%82%a2%e3%83%9f%e3%83%ad%e3%82%a4%e3%83%89%e5%bf%83%e7%ad%8b%e7%97%87%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b/Medxy AIja2026-05-10T16:47:12-07:00CARDIO-TTRansformの理由と設計: Transthyretin アミロイド心筋症に対するフェーズ3試験 https://news.medxy.ai/zh/cardio-ttransform%e7%a0%94%e7%a9%b6%ef%bc%9a%e7%94%a8%e4%ba%8e%e8%bd%ac%e7%94%b2%e7%8a%b6%e8%85%ba%e7%b4%a0%e8%9b%8b%e7%99%bd%e6%b7%80%e7%b2%89%e6%a0%b7%e5%bf%83%e8%82%8c%e7%97%85%e7%9a%84eplontersen/Medxy AIzh2026-05-10T16:46:11-07:00CARDIO-TTRansform研究：用于转甲状腺素蛋白淀粉样心肌病的Eplontersen III期试验的原理与设计 https://news.medxy.ai/rationale-and-design-of-cardio-ttransform-a-phase-3-trial-of-eplontersen-for-transthyretin-amyloid-cardiomyopathy/Medxy AIen2026-05-10T16:43:38-07:00Rationale and Design of CARDIO-TTRansform: A Phase 3 Trial of Eplontersen for Transthyretin Amyloid Cardiomyopathy https://news.medxy.ai/vi/mo-hinh-va-xu-huong-gioi-tinh-trong-cay-ghep-van-dong-mach-chu-qua-catheter/Medxy AIvi2026-05-10T16:41:31-07:00Mô hình và xu hướng giới tính trong cấy ghép van động mạch chủ qua catheter https://news.medxy.ai/ja/%e6%80%a7%e5%88%a5%e3%81%ab%e5%9f%ba%e3%81%a5%e3%81%8f%e7%b5%8c%e3%82%ab%e3%83%86%e3%83%bc%e3%83%86%e3%83%ab%e5%a4%a7%e5%8b%95%e8%84%88%e5%bc%81%e6%a4%8d%e8%be%bc%e8%a1%93%e3%81%ae%e3%83%91%e3%82%bf/Medxy AIja2026-05-10T16:40:41-07:00性別に基づく経カテーテル大動脈弁植込術のパターンと傾向 https://news.medxy.ai/zh/%e5%9f%ba%e4%ba%8e%e6%80%a7%e5%88%ab%e7%9a%84%e7%bb%8f%e5%af%bc%e7%ae%a1%e4%b8%bb%e5%8a%a8%e8%84%89%e7%93%a3%e6%a4%8d%e5%85%a5%e6%9c%af%e6%a8%a1%e5%bc%8f%e4%b8%8e%e8%b6%8b%e5%8a%bf/Medxy AIzh2026-05-10T16:39:40-07:00基于性别的经导管主动脉瓣植入术模式与趋势 https://news.medxy.ai/sex-based-patterns-and-trends-in-transcatheter-aortic-valve-implantation/Medxy AIen2026-05-10T16:37:45-07:00Sex-Based Patterns and Trends in Transcatheter Aortic Valve Implantation https://news.medxy.ai/zh/%e5%9c%a8%e5%a4%8d%e6%9d%82pci%e4%b8%ad%e4%bc%98%e5%8c%96%e6%8a%97%e8%a1%80%e5%b0%8f%e6%9d%bf%e7%ad%96%e7%95%a5%ef%bc%9atailored-chip%e8%af%95%e9%aa%8c%e5%8f%8a%e5%85%b6%e6%bc%94%e5%8f%98%e8%af%81/Medxy AIzh2026-05-09T22:28:47-07:00在复杂PCI中优化抗血小板策略：TAILORED-CHIP试验及其演变证据对时间调制的影响 https://news.medxy.ai/ja/%e8%a4%87%e9%9b%91%e3%81%aapci%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e6%8a%97%e8%a1%80%e5%b0%8f%e6%9d%bf%e6%88%a6%e7%95%a5%e3%81%ae%e6%9c%80%e9%81%a9%e5%8c%96%ef%bc%9atailored-chip%e8%a9%a6%e9%a8%93/Medxy AIja2026-05-09T22:27:21-07:00複雑なPCIにおける抗血小板戦略の最適化：TAILORED-CHIP試験と時間制御の進展から得られる洞察 https://news.medxy.ai/vi/toi-uu-hoa-chien-luoc-chong-tieu-cau-trong-pci-phuc-tap-nhung-hieu-biet-tu-thu-nghiem-tailored-chip-va-bang-chung-tien-trien-ve-dieu-chinh-thoi-gian/Medxy AIvi2026-05-09T22:24:03-07:00Tối ưu hóa chiến lược chống tiểu cầu trong PCI phức tạp: Những hiểu biết từ thử nghiệm TAILORED-CHIP và bằng chứng tiến triển về điều chỉnh thời gian https://news.medxy.ai/optimizing-antiplatelet-strategies-in-complex-pci-insights-from-the-tailored-chip-trial-and-evolving-evidence-for-temporal-modulation/Medxy AIen2026-05-09T22:21:13-07:00Optimizing Antiplatelet Strategies in Complex PCI: Insights from the TAILORED-CHIP Trial and Evolving Evidence for Temporal Modulation https://news.medxy.ai/a-new-hs-ctnt-generation-6-assay-matches-generation-5-for-myocardial-infarction-diagnosis-while-labeling-fewer-patients-as-myocardially-injured/Medxy AIen2026-05-09T21:54:42-07:00A New hs-cTnT Generation 6 Assay Matches Generation 5 for Myocardial Infarction Diagnosis While Labeling Fewer Patients as Myocardially Injured https://news.medxy.ai/vi/xac-dinh-nguong-sinh-ly-cho-dau-that-nguc-orbita-fire-mot-nghien-cuu-ngau-nhien-doi-chung-gia-mu-doi/Medxy AIvi2026-05-09T21:07:10-07:00Xác định Ngưỡng Sinh lý cho Đau thắt ngực (ORBITA-FIRE): Một Nghiên cứu Ngẫu nhiên, Đối chứng giả, Mù đôi https://news.medxy.ai/ja/%e5%bf%83%e7%b5%9e%e7%97%9b%e3%81%ae%e7%94%9f%e7%90%86%e5%ad%a6%e7%9a%84%e9%96%be%e5%80%a4%e3%82%92%e6%b1%ba%e5%ae%9a%e3%81%99%e3%82%8b%ef%bc%88orbita-fire%ef%bc%89%ef%bc%9a%e4%ba%8c%e9%87%8d%e7%9b%b2/Medxy AIja2026-05-09T21:05:39-07:00心絞痛の生理学的閾値を決定する（ORBITA-FIRE）：二重盲検無作為化プラセボ対照試験 https://news.medxy.ai/zh/%e7%a1%ae%e5%ae%9a%e5%bf%83%e7%bb%9e%e7%97%9b%e7%9a%84%e7%94%9f%e7%90%86%e9%98%88%e5%80%bc%ef%bc%88orbita-fire%ef%bc%89%ef%bc%9a%e4%b8%80%e9%a1%b9%e5%8f%8c%e7%9b%b2%e3%80%81%e9%9a%8f%e6%9c%ba%e3%80%81/Medxy AIzh2026-05-09T21:04:36-07:00确定心绞痛的生理阈值（ORBITA-FIRE）：一项双盲、随机、安慰剂对照研究 https://news.medxy.ai/determining-the-physiological-threshold-for-angina-orbita-fire-a-double-blind-randomized-placebo-controlled-study/Medxy AIen2026-05-09T21:01:51-07:00Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study